A planning committee of the National Academies of Sciences, Engineering, and Medicine will organize and host a 1.5-day public workshop to examine current issues in the development and implementation of effective, high-quality cancer screening. The workshop will feature invited presentations and panel discussions on topics that may include:

• Key gaps in the evidence base for cancer screening tests, as well as methodological and statistical challenges in assessing the potential benefits and risks of screening.
• Opportunities and challenges in developing, validating, and implementing new technologies for cancer screening tests, such as liquid biopsies and biomarkers of cancer risk.
• Strategies to help patients understand the benefits, risks, and costs of cancer screening and participate in shared decision-making with their care team about screening options.
• Challenges in the clinical management of patients with premalignant lesions detected by screening.
• Opportunities to reduce disparities in cancer morbidity and mortality by facilitating patient access to high-quality screening and diagnosis in low-resource areas and among vulnerable populations.
• Strategies to ensure that screened patients diagnosed with cancer have timely access to high-quality cancer treatment.

The planning committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.